ALHCNasdaqHospital & Medical Service PlansFiscal year ends December 31
Alignment Healthcare, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$8.40+0.12 (+1.45%)
Close on Oct 19, 2026
- Market cap
- $1.81B
- P/E (TTM)
- 49.4
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
222M of 207M shares
Institutional holders
323
80 new, 46 sold out
Net institutional buying
21M
In Q2 2026
Insider trades, 12 months
1 buys · 79 sales
Net sold $520.63M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| GAP Coinvestments V, LLC | 43,993,323 | 22.20% | 13G (passive) amendment | Jun 30, 2025 |
| General Atlantic (ALN HLTH), L.P. | 24,287,227 | 12.30% | 13G (passive) amendment | Sep 17, 2025 |
| BlackRock, Inc. | 23,530,373 | 11.30% | 13G (passive) amendment | Sep 30, 2026 |
| Wellington Investment Advisors Holdings LLP | 17,098,936 | 8.40% | 13G (passive) amendment | Mar 31, 2026 |
| Abigail P. Johnson | 14,792,082 | 7.70% | 13G (passive) | Dec 31, 2025 |
| Wellington Management Company LLP | 14,070,893 | 7.00% | 13G (passive) amendment | Dec 31, 2025 |
| Q Healthcare Holding LLC | 13,246,096 | 6.69% | 13G (passive) | Sep 17, 2025 |
| T. Rowe Price Investment Management, Inc. | 12,331,720 | 6.20% | 13G (passive) | Jun 30, 2025 |
| Vanguard Portfolio Management | 11,874,585 | 5.74% | 13G (passive) | Jun 30, 2026 |
| Wellington Management Group LLP | 11,089,727 | 5.60% | 13G (passive) | Sep 30, 2025 |
| Invesco Ltd. | 10,365,640 | 5.00% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ALHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 19,342,956 | 9.32% | $460.56M | +5,267,759 | 0.01% |
| Wellington Management Group Llp | 18,780,363 | 9.05% | $447.16M | +1,681,427 | 0.08% |
| FMR LLC | 13,924,329 | 6.71% | $331.54M | −1,967,735 | 0.01% |
| T. Rowe Price Investment Management, Inc. | 13,119,557 | 6.32% | $312.38K | −28,099 | 0.20% |
| Vanguard Portfolio Management LLC | 11,672,259 | 5.63% | $277.92M | +1,962,188 | 0.01% |
| Invesco Ltd. | 10,365,640 | 5.00% | $246.81M | +3,365,541 | 0.02% |
| Bank Of America Corp /De/ | 9,346,742 | 4.51% | $222.55M | +6,131,075 | 0.01% |
| Vanguard Capital Management LLC | 8,144,247 | 3.93% | $193.91M | +170,584 | 0.00% |
| William Blair Investment Management, LLC | 7,761,403 | 3.74% | $184.80M | +2,546,789 | 0.56% |
| State Street Corp | 7,297,494 | 3.52% | $173.75M | +3,003,800 | 0.01% |
| Hood River Capital Management LLC | 6,184,526 | 2.98% | $147.25M | +130,049 | 1.07% |
| Price T Rowe Associates Inc /Md/ | 4,939,145 | 2.38% | $117.60K | −802,161 | 0.01% |
| Geode Capital Management, LLC | 4,845,510 | 2.34% | $115.39M | +434,170 | 0.01% |
| Capital Research Global Investors | 4,399,329 | 2.12% | $104.75M | +805,753 | 0.01% |
| Goldman Sachs Group Inc | 4,013,339 | 1.93% | $95.56M | +3,001,689 | 0.01% |
| Capital World Investors | 3,910,131 | 1.88% | $93.10M | +1,244,073 | 0.01% |
| Danica Pension, Livsforsikringsaktieselskab | 3,687,259 | 1.78% | $87.79M | +1,183,682 | 1.40% |
| Bank of New York Mellon Corp | 3,657,160 | 1.76% | $87.08M | +344,050 | 0.01% |
| Allspring Global Investments Holdings, LLC | 3,053,525 | 1.47% | $73.32M | +595,125 | 0.11% |
| Next Century Growth Investors LLC | 2,537,598 | 1.22% | $60.42M | +275,522 | 3.20% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 323 | 222M | 100.0% | 80 / 142 | 81 / 46 | 53M | 32M |
| Q1 2026 | 293 | 202M | 97.2% | 77 / 111 | 75 / 42 | 53M | 28M |
| Q4 2025 | 263 | 193M | 93.2% | 55 / 128 | 63 / 25 | 38M | 28M |
| Q3 2025 | 236 | 184M | 88.8% | 55 / 97 | 70 / 35 | 36M | 40M |
| Q2 2025 | 217 | 188M | 90.9% | 53 / 102 | 50 / 41 | 44M | 38M |
| Q1 2025 | 207 | 183M | 88.2% | 53 / 95 | 42 / 17 | 24M | 17M |
| Q4 2024 | 172 | 176M | 85.0% | 47 / 66 | 38 / 11 | 30M | 21M |
| Q3 2024 | 137 | 167M | 80.5% | 30 / 45 | 42 / 10 | 19M | 12M |
| Q2 2024 | 118 | 168M | 81.0% | 19 / 52 | 34 / 30 | 12M | 9M |
| Q1 2024 | 130 | 165M | 79.5% | 28 / 36 | 45 / 19 | 14M | 13M |
| Q4 2023 | 121 | 164M | 78.9% | 10 / 41 | 48 / 20 | 6M | 4M |
| Q3 2023 | 131 | 162M | 78.0% | 18 / 50 | 43 / 27 | 5M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ALHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | 7,393,726 | 3.56% | $176.04M | 0.19% | Jun 30, 2026 |
| Vanguard Health Care Fund | 6,928,007 | 3.34% | $102.88M | 0.27% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 5,893,898 | 2.84% | $140.33M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 4,587,528 | 2.21% | $109.23M | 0.13% | Jun 30, 2026 |
| iShares Core S&P Small-Cap ETF | 4,555,244 | 2.20% | $108.46M | 0.10% | Jun 30, 2026 |
| Invesco Discovery Fund | 4,299,086 | 2.07% | $65.86M | 0.84% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 4,268,708 | 2.06% | $101.64M | 0.05% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 4,164,540 | 2.01% | $99.16M | 1.07% | Jun 30, 2026 |
| Hood River Small-Cap Growth Fund | 4,079,124 | 1.97% | $97.12M | 1.46% | Jun 30, 2026 |
| Select Health Care Portfolio | 2,600,000 | 1.25% | $39.83M | 0.69% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,457,966 | 1.18% | $58.52M | 0.12% | Jun 30, 2026 |
| T. Rowe Price Institutional Small-Cap Stock Fund | 2,270,563 | 1.09% | $54.06M | 1.08% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,232,675 | 1.08% | $33.16M | 0.10% | Jul 31, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 2,190,075 | 1.06% | $52.15M | 0.35% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 2,016,767 | 0.97% | $48.02M | 0.45% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joseph S. Konowiecki | EVP, Corporate Affairs, Director | 1,080,305 | 0.52% | Sep 18, 2026 |
| John E. Kao | Chief Executive Officer, Director | 1,814,239 | 0.87% | Sep 16, 2026 |
| Dawn Christine Maroney | President | 794,606 | 0.38% | Sep 11, 2026 |
| Shane J. Hochradel | Chief Operations Officer | 87,719 | 0.04% | Jul 2, 2026 |
| Hyong Kim | Chief Medical Officer | 331,750 | 0.16% | Jun 15, 2026 |
| Mark D. Kent | President - MSO | 102,567 | 0.05% | Jun 9, 2026 |
| James M. Head | Chief Financial Officer | 173,495 | 0.08% | Apr 8, 2026 |
| Christopher J. Joyce | Chief Legal and Admin. Officer | 305,451 | 0.15% | Apr 1, 2026 |
| Sebastian Burzacchi | COO - Mgmt Services Org | 258,630 | 0.12% | Mar 19, 2026 |
| Robert L. Scavo | Chief Information Officer | 487,685 | 0.24% | Mar 19, 2026 |
| Andreas P. Wagner | Chief Human Resources Officer | 148,628 | 0.07% | Mar 19, 2026 |
| Adnan R. Mansour | Chief Digital Officer | 48,456 | 0.02% | Mar 17, 2026 |
| Hakan Kardes | Chief Experience Officer | 678,987 | 0.33% | Mar 28, 2025 |
| Robert Thomas Freeman | Chief Financial Officer | 1,557,348 | 0.75% | Mar 28, 2025 |
| Mark B. McClellan | Director | 370,531 | 0.18% | Mar 17, 2026 |
| Yon Jorden | Director | 105,830 | 0.05% | Mar 17, 2026 |
| Nicholas Robbert Vorhoff | Director | 173,408 | 0.08% | Mar 17, 2026 |
| Jacqueline B. Kosecoff | Director | 303,963 | 0.15% | Mar 17, 2026 |
| Margaret M. McCarthy | Director | 144,441 | 0.07% | Mar 17, 2026 |
| Jody L. Bilney | Director | 129,267 | 0.06% | Mar 17, 2026 |
| David C. Hodgson | Director | 173,408 | 0.08% | Mar 17, 2026 |
| GAP Coinvestments V, LLC | 10% owner | 61,302,175 | 29.55% | Dec 12, 2025 |
| Gmbh & Co Kg Gapco | 10% owner | 78,511,411 | 37.85% | Dec 12, 2025 |
| General Atlantic, L.P. | 10% owner | 76,328,615 | 36.80% | Dec 12, 2025 |
| GAP Coinvestments CDA, L.P. | 10% owner | 30,842,175 | 14.87% | Dec 12, 2025 |
| Gap Coinvestments Iv, Llc | 10% owner | – | – | Dec 12, 2025 |
| General Atlantic Genpar, L.P. | 10% owner | 13,476,585 | 6.50% | Dec 12, 2025 |
| Gap Coinvestments Iii, Llc | 10% owner | – | – | Dec 12, 2025 |
| General Atlantic Partners 95, L.P. | 10% owner | 24,596,079 | 11.86% | Dec 12, 2025 |
| General Atlantic (SPV) GP, LLC | 10% owner | 67,949,317 | 32.76% | Dec 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Sep 17, 2026 | Sale | −23,511 | $8.61 | $202.43K | 1,080,305 |
| John E. Kao Chief Executive Officer, Director | Sep 14, 2026 | Sale(10b5-1 plan) | −27,400 | $13.00 | $356.20K | 590,766 |
| Dawn Christine Maroney President | Sep 11, 2026 | Sale | −122,707 | $12.68 | $1.56M | 794,606 |
| John E. Kao Chief Executive Officer, Director | Sep 11, 2026 | Sale(10b5-1 plan) | −385,270 | $12.68 | $4.89M | 1,223,473 |
| John E. Kao Chief Executive Officer, Director | Sep 10, 2026 | Sale(10b5-1 plan) | −172,600 | $12.96 | $2.24M | 618,166 |
| Dawn Christine Maroney President | Aug 14, 2026 | Sale(10b5-1 plan) | −5,000 | $14.00 | $70.00K | 917,313 |
| John E. Kao Chief Executive Officer, Director | Aug 10, 2026 | Sale(10b5-1 plan) | −298,000 | $13.88 | $4.14M | 790,766 |
| Dawn Christine Maroney President | Jul 15, 2026 | Option exercise | +152,068 | $9.06 | $1.38M | 1,099,381 |
| Dawn Christine Maroney President | Jul 15, 2026 | Sale(10b5-1 plan) | −177,068 | $20.83 | $3.69M | 922,313 |
| John E. Kao Chief Executive Officer, Director | Jul 10, 2026 | Sale(10b5-1 plan) | −18,356 | $20.65 | $379.05K | 1,088,766 |
| John E. Kao Chief Executive Officer, Director | Jul 10, 2026 | Sale(10b5-1 plan) | −279,644 | $19.81 | $5.54M | 1,107,122 |
| Shane J. Hochradel Chief Operations Officer | Jul 1, 2026 | Award | +87,719 | – | – | 87,719 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jul 1, 2026 | Sale(10b5-1 plan) | −25,000 | $24.00 | $600.00K | 1,103,816 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 26, 2026 | Sale(10b5-1 plan) | −25,000 | $23.00 | $575.00K | 1,128,816 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 18, 2026 | Sale(10b5-1 plan) | −25,000 | $22.00 | $550.00K | 1,153,816 |
| Dawn Christine Maroney President | Jun 15, 2026 | Sale(10b5-1 plan) | −30,000 | $19.55 | $586.50K | 947,313 |
| Hyong Kim Chief Medical Officer | Jun 12, 2026 | Sale(10b5-1 plan) | −35,951 | $19.86 | $713.99K | 331,750 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 11, 2026 | Sale(10b5-1 plan) | −25,000 | $21.00 | $525.00K | 1,178,816 |
| John E. Kao Chief Executive Officer, Director | Jun 10, 2026 | Sale(10b5-1 plan) | −223,064 | $20.60 | $4.60M | 1,386,766 |
| John E. Kao Chief Executive Officer, Director | Jun 10, 2026 | Sale(10b5-1 plan) | −74,936 | $19.65 | $1.47M | 1,609,830 |
| Mark D. Kent President - MSO | Jun 3, 2026 | Award | +87,719 | – | – | 102,567 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 3, 2026 | Award | +122,807 | – | – | 1,203,816 |
| Mark D. Kent President - MSO | Jun 2, 2026 | Buy | +14,848 | $13.31 | $197.63K | 14,848 |
| Dawn Christine Maroney President | May 18, 2026 | Gift | −20,000 | – | – | 977,313 |
| Dawn Christine Maroney President | May 15, 2026 | Sale(10b5-1 plan) | −30,000 | $16.09 | $482.70K | 998,813 |
| Dawn Christine Maroney President | May 15, 2026 | Gift | −1,500 | – | – | 997,313 |
| John E. Kao Chief Executive Officer, Director | May 11, 2026 | Sale(10b5-1 plan) | −17,107 | $17.54 | $300.06K | 1,508,641 |
| John E. Kao Chief Executive Officer, Director | May 11, 2026 | Sale(10b5-1 plan) | −280,893 | $16.85 | $4.73M | 1,525,748 |
| Dawn Christine Maroney President | Apr 15, 2026 | Sale(10b5-1 plan) | −30,000 | $20.87 | $626.10K | 1,028,813 |
| John E. Kao Chief Executive Officer, Director | Apr 13, 2026 | Sale(10b5-1 plan) | −82,299 | $20.80 | $1.71M | 1,806,641 |
| John E. Kao Chief Executive Officer, Director | Apr 10, 2026 | Sale(10b5-1 plan) | −13,801 | $21.38 | $295.07K | 1,888,940 |
| John E. Kao Chief Executive Officer, Director | Apr 10, 2026 | Sale(10b5-1 plan) | −201,900 | $20.58 | $4.16M | 1,902,741 |
| James M. Head Chief Financial Officer | Apr 7, 2026 | Sale | −11,100 | $21.08 | $233.99K | 173,495 |
| John E. Kao Chief Executive Officer, Director | Apr 7, 2026 | Sale(10b5-1 plan) | −132,241 | $20.67 | $2.73M | 2,222,400 |
| John E. Kao Chief Executive Officer, Director | Apr 7, 2026 | Sale(10b5-1 plan) | −117,759 | $21.40 | $2.52M | 2,104,641 |
| Christopher J. Joyce Chief Legal and Admin. Officer | Apr 1, 2026 | Sale(10b5-1 plan) | −18,013 | $17.79 | $320.45K | 305,451 |
| John E. Kao Chief Executive Officer, Director | Mar 23, 2026 | Sale(10b5-1 plan) | −118,000 | $17.48 | $2.06M | 2,354,641 |
| Andreas P. Wagner Chief Human Resources Officer | Mar 19, 2026 | Sale(10b5-1 plan) | −11,602 | $18.22 | $211.39K | 148,628 |
| Christopher J. Joyce Chief Legal and Admin. Officer | Mar 18, 2026 | Sale | −25,125 | $17.84 | $448.23K | 323,464 |
| Dawn Christine Maroney President | Mar 18, 2026 | Sale | −36,749 | $17.84 | $655.60K | 1,058,813 |
| Sebastian Burzacchi COO - Mgmt Services Org | Mar 18, 2026 | Sale | −15,361 | $17.84 | $274.04K | 258,630 |
| Hyong Kim Chief Medical Officer | Mar 18, 2026 | Sale | −18,404 | $17.84 | $328.33K | 367,701 |
| Andreas P. Wagner Chief Human Resources Officer | Mar 18, 2026 | Sale(10b5-1 plan) | −12,000 | $17.84 | $214.08K | 160,230 |
| John E. Kao Chief Executive Officer, Director | Mar 18, 2026 | Sale | −73,046 | $17.84 | $1.30M | 1,784,868 |
| Robert L. Scavo Chief Information Officer | Mar 18, 2026 | Sale | −11,285 | $17.84 | $201.32K | 487,685 |
| Dawn Christine Maroney President | Mar 16, 2026 | Sale(10b5-1 plan) | −30,000 | $17.48 | $524.40K | 1,095,562 |
| Yon Jorden Director | Mar 13, 2026 | Award | +13,096 | – | – | 105,830 |
| James M. Head Chief Financial Officer | Mar 13, 2026 | Award | +103,002 | – | – | 184,595 |
| Christopher J. Joyce Chief Legal and Admin. Officer | Mar 13, 2026 | Award | +51,501 | – | – | 348,589 |
| David C. Hodgson Director | Mar 13, 2026 | Award | +18,982 | – | – | 173,408 |
| Joseph S. Konowiecki Director | Mar 13, 2026 | Award | +24,868 | – | – | 1,081,009 |
| Hyong Kim Chief Medical Officer | Mar 13, 2026 | Award | +52,972 | – | – | 386,105 |
| John E. Kao Chief Executive Officer, Director | Mar 13, 2026 | Award | +338,434 | – | – | 1,857,914 |
| Jody L. Bilney Director | Mar 13, 2026 | Award | +16,039 | – | – | 129,267 |
| Andreas P. Wagner Chief Human Resources Officer | Mar 13, 2026 | Award | +23,543 | – | – | 172,230 |
| Adnan R. Mansour Chief Digital Officer | Mar 13, 2026 | Award | +25,015 | – | – | 48,456 |
| Margaret M. McCarthy Director | Mar 13, 2026 | Award | +14,273 | – | – | 144,441 |
| Mark B. McClellan Director | Mar 13, 2026 | Award | +13,096 | – | – | 370,531 |
| Nicholas Robbert Vorhoff Director | Mar 13, 2026 | Award | +18,982 | – | – | 173,408 |
| Jacqueline B. Kosecoff Director | Mar 13, 2026 | Award | +13,096 | – | – | 303,963 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Hyong (Ken) Kim, M.D. Chief Medical Officer | Oct 5, 2026 | 36,000 | $305.28K | Oct 6, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 10/04/2023 under the Issuer's 2021 Equity Incentive Plan |
| Konowiecki Joseph Director / EVP, Corporate Affairs | Sep 16, 2026 | 26,000 | $226.46K | Sep 17, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 09/14/2023 under the Issuer's 2021 Equity Incentive Plan |
| Trust U/A Dtd 02/08/2021 Jek Director, Officer | Sep 10, 2026 | 500,000 | $6.52M | Sep 10, 2026 | Shares Issued Pre-IPO in exchange for Partnership Units |
| C. Maroney Dawn President | Sep 9, 2026 | 130,000 | $1.70M | Sep 10, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan |
| Kao John Chief Executive Officer / Director | Sep 9, 2026 | 405,000 | $5.29M | Sep 10, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan |
| Maroney Dawn Officer | Aug 14, 2026 | 5,000 | $67.30K | Aug 14, 2026 | RSU/PSU |
| Maroney Dawn Officer | Jul 15, 2026 | 177,068 | $3.75M | Jul 15, 2026 | Exercise of Stock Options |
| Trust U/A Dtd 02/08/2021 Jek Director, Officer | Jul 10, 2026 | 596,000 | $12.53M | Jul 10, 2026 | Shares Issued Pre-IPO in exchange for Partnership Units |
| Konowiecki Joseph Director | Jul 1, 2026 | 25,000 | $600.00K | Jul 1, 2026 | Stock Bonus |
| Konowiecki Joseph Director | Jun 26, 2026 | 25,000 | $575.00K | Jun 26, 2026 | Stock Bonus |
| Konowiecki Joseph Director | Jun 18, 2026 | 25,000 | $550.00K | Jun 18, 2026 | Stock Bonus |
| Burzacchi Sebastian Officer | Jun 12, 2026 | 1,142 | $23.11K | Jun 12, 2026 | Restricted Stock Units |
| J. Kim Hyong Officer | Jun 12, 2026 | 35,951 | $727.65K | Jun 12, 2026 | Restricted Stock Units |
| Konowiecki Joseph Director | Jun 11, 2026 | 25,000 | $525.00K | Jun 11, 2026 | Stock Bonus |
| Trust U/A Dtd 02/08/2021 Jek Director, Officer | May 11, 2026 | 596,000 | $10.69M | May 11, 2026 | Shares Issued Pre-IPO in exchange for Partnership Units |